EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride): In Vitro Protocol Guide

What This Product Solves

EDC.HCl, also known as 3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride (CAS 25952-53-8), addresses the need for a water-soluble carbodiimide reagent in peptide synthesis, bioconjugation, and nucleotide synthesis workflows. It facilitates direct amide bond formation between carboxyl and primary amine groups in aqueous environments, converting to a urea byproduct. This property makes it highly practical as a peptide synthesis coupling reagent and bioconjugation reagent, especially where water solubility and minimal side reactions are necessary. The reagent also finds use as an esterification reagent and nucleotide synthesis reagent. For protocols demanding strict control over amide bond formation in vitro, EDC.HCl is a preferred choice due to its compatibility with aqueous systems and straightforward workup.

For further technical insights and workflow adaptations, see: Technical Guidelines (overview of in vitro uses and storage) and Technical Guide for Peptide and Bioconjugation Protocols (focus on amide bond formation workflows).

Protocol Parameters

• Solubility in water | ≥39 mg/mL | Solution preparation for aqueous coupling reactions | Ensures sufficient reagent concentration for efficient amide bond formation, minimizing precipitation and maximizing yield | product dossier
• Recommended storage conditions | Solid, desiccated at -20°C | Long-term storage and batch consistency | Prevents hydrolysis and degradation of the reagent, preserving reactivity and avoiding variability between experiments | product dossier
• Maximum stability of prepared solutions | Avoid long-term storage; prepare fresh before use | Solution handling in peptide and bioconjugation workflows | EDC.HCl solutions are prone to hydrolysis; freshly prepared solutions maintain optimal coupling efficiency and reproducibility | product dossier

Additional Parameters and Workflow Recommendations

• Monitoring reagent consumption | Spectrophotometric methods | Quality control during reaction setup | Enables quantitative tracking of EDC.HCl and byproduct formation to optimize reaction endpoints | product dossier
• Concentration for DMSO solubilization | ≥19.2 mg/mL | Non-aqueous and mixed-solvent protocols | Expands application scope for protocols requiring organic co-solvents | product dossier

Workflow Setup and QC Checklist

1. Confirm the integrity and dryness of EDC.HCl upon receipt; store as a solid in a desiccator at -20°C to prevent moisture-induced decomposition.
2. For aqueous protocols, dissolve EDC.HCl at concentrations up to 39 mg/mL in deionized water immediately before use. For organic or mixed-phase reactions, DMSO or ethanol may be used as solvents within the specified solubility limits.
3. Prepare all solutions fresh; avoid prolonged storage of EDC.HCl in solution to minimize hydrolysis and loss of activity.
4. Set up the reaction by combining activated carboxyl (substrate) and primary amine components with EDC.HCl under the appropriate buffer and pH conditions (typically pH 4.5–7.5, as recommended in peptide coupling workflows).
5. Monitor reaction progress and reagent consumption using spectrophotometric or analytical HPLC methods where feasible.
6. Quench and purify the reaction as soon as coupling is complete to minimize side-product formation from carbodiimide hydrolysis or O-acylisourea intermediates.
7. Document batch numbers, preparation details, and QC results to support reproducibility and troubleshooting.

Common Failure Modes and Fixes

• Low coupling efficiency or incomplete reaction: Check EDC.HCl freshness and ensure solid has been stored desiccated at -20°C. Prepare solutions immediately before use and verify concentrations are within recommended ranges. If persistent, confirm substrate purity and optimize pH for the specific workflow.
• Precipitation or insolubility: Assess whether EDC.HCl has exceeded its solubility threshold in the chosen solvent. For aqueous protocols, do not exceed 39 mg/mL; for DMSO, remain below 19.2 mg/mL. If precipitation persists, consider solvent adjustments or sequence of reagent addition.
• Excessive urea byproduct or side reactions: Minimize reaction time and promptly quench or purify after coupling. Store EDC.HCl solutions only as briefly as necessary, and avoid excess reagent which may increase byproduct formation.
• Batch-to-batch variability: Implement routine QC checks (e.g., spectrophotometric analysis) and track storage conditions and handling history for each lot of EDC.HCl.

Scope and Limitations

EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is optimized for in vitro biochemical applications, including peptide synthesis, bioconjugation, and nucleotide coupling. Its water solubility and activation mechanism are advantageous in controlled laboratory workflows where amide or ester bond formation is required. The reagent is not supported for in vivo or clinical use, as noted in both the product documentation and internal technical guidelines. Protocols that require long-term solution stability, or that cannot accommodate rapid reagent turnover, may not be compatible with EDC.HCl due to its hydrolytic sensitivity. Researchers should also be aware of potential side reactions with unprotected substrates and adjust workflow parameters accordingly.

Conclusion

For in vitro workflows demanding efficient amide bond formation, EDC.HCl offers a practical, water-soluble carbodiimide option for peptide synthesis, bioconjugation, and nucleotide coupling. Adhering to recommended storage, solution preparation, and QC practices is essential for reproducibility. For detailed product characteristics and ordering information, refer to EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) from APExBIO. Researchers should restrict use to in vitro protocols, as no in vivo or clinical data are available for this reagent.